The effect of selected molecules influencing the detrimental host immune response on a course of rabies virus infection in a murine model.

scientific article published on 15 November 2017

The effect of selected molecules influencing the detrimental host immune response on a course of rabies virus infection in a murine model. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VACCINE.2017.10.098
P698PubMed publication ID29153584

P50authorAb OsterhausQ354237
Jan Franciszek ŻmudzińskiQ11717471
Michał ReichertQ11779161
Anna MarzecQ88344884
Marcin SmreczakQ89976803
Anna KyckoQ94556389
Paweł TrębasQ125344472
P2093author name stringAnna Orłowska
Penelopa Koraka
P2860cites workAmbivalent role of the innate immune response in rabies virus pathogenesisQ24300579
Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinasesQ24632768
TNF inhibitor therapy for rheumatoid arthritisQ28972424
Rabies virus-induced activation of mitogen-activated protein kinase and NF-kappaB signaling pathways regulates expression of CXC and CC chemokine ligands in microgliaQ33987385
Met-CCL5 represents an immunotherapy strategy to ameliorate rabies virus infection.Q34571301
Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinasesQ35221333
Profile of Cytokines and Chemokines Triggered by Wild-Type Strains of Rabies Virus in MiceQ36575430
GRP78/Dna K Is a Target for Nexavar/Stivarga/Votrient in the Treatment of Human Malignancies, Viral Infections and Bacterial DiseasesQ36830763
The importance of immune evasion in the pathogenesis of rabies virus.Q37157195
Raf inhibitors as therapeutic agents against neurodegenerative diseasesQ37702342
Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases.Q37854935
Tocilizumab: a novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseasesQ38104740
TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and futureQ38244471
Modern anti-cytokine therapy of autoimmune diseasesQ38365336
The type I interferon response bridles rabies virus infection and reduces pathogenicityQ39497376
Interleukin-6 inhibitors in the treatment of rheumatoid arthritis.Q40003399
Exogenous interferon prolongs survival of rabies infected mice.Q40986580
Pathobiology of rabies virus and the European bat lyssaviruses in experimentally infected mice.Q42280815
Sorafenib induces growth suppression in mouse models of gastrointestinal stromal tumorQ44054852
Silver-haired bat rabies virus variant does not induce apoptosis in the brain of experimentally infected miceQ45734834
Up-regulation of chemokine gene transcripts and T-cell infiltration into the central nervous system and dorsal root ganglia are characteristics of experimental European bat lyssavirus type 2 infection of miceQ56773297
Glycoprotein-mediated induction of apoptosis limits the spread of attenuated rabies viruses in the central nervous system of miceQ60696936
P433issue33
P407language of work or nameEnglishQ1860
P921main subjectrabiesQ39222
rabies virusQ698976
murine modelQ122890741
P304page(s)4715-4723
P577publication date2017-11-15
P1433published inVaccineQ7907941
P1476titleThe effect of selected molecules influencing the detrimental host immune response on a course of rabies virus infection in a murine model
P478volume37

Reverse relations

cites work (P2860)
Q56576670Combination drug treatment prolongs survival of experimentally infected mice with silver-haired bat rabies virus
Q59353657Inhibition of MALT1 decreases neuroinflammation and pathogenicity of virulent rabies virus in mice
Q54236746The effect of combined drugs therapy on the course of clinical rabies infection in a murine model.

Search more.